Navigation Links
President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities
Date:2/4/2008

WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- "Congress must reject President Bush's Fiscal Year 2009 budget in order to address the critical health needs of the over 1.1 million people living with HIV/AIDS in the United States," commented Dr. Gene Copello, Executive Director of The AIDS Institute. "Most of the people who rely on these government programs for their healthcare and medicines are very poor and from minority communities. As the richest nation in the world, we can't turn our backs on them. The budget the President has recommended ignores our Nation's healthcare priorities and must be rejected."

"We must also turn to the Congress to increase HIV prevention funding at the CDC. At the same time the Centers for Disease Prevention and Control (CDC) is about to release higher HIV incidence numbers for the U.S., and is embarking on increasing HIV testing and case finding programs, the President is proposing to cut HIV prevention programs," Copello continued.

"It is appalling that the President is recommending a measly $1 million or .004% increase for the Ryan White CARE Act, which provides healthcare and medications for low-income people living with HIV/AIDS," added Copello. "This does not even keep up with inflation, let alone take in account that more people need services due to new infections, new testing initiatives, and people are living longer. We will now have to turn to the Congress to adequately fund HIV/AIDS care and treatment."

Many parts of the Ryan White program have faced cuts in recent years despite the growing demand. For the current year, HIV/AIDS funding for state health departments was cut by $19 million at the same time state budgets are being stretched due to the economic downturn. The President is proposing an increase of only $6 million for the AIDS Drug Assistance Program (ADAP) which provides lifesaving medications. This does not come close to the anticipated needed increase of $133 million. Despite this mino
'/>"/>

SOURCE The AIDS Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AIDS Action Calls Presidents FY 2009 Budget Request Shameful
2. Bushs Budget Proposal Would Cut Medicare Funding
3. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
4. Will This President Never Learn? Another Budget -- Another Increase to Ineffective Abstinence-Only Programs
5. Medicare Cuts in Bush Budget Shortsighted, Far Off the Mark in Protecting Seniors Long Term Care Needs, Sustaining Nursing Home Quality Gains
6. AACN Concerned That the Presidents FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage
7. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
8. FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs
9. Home Oxygen Care Leaders Say Presidents Budget Will Lead to Significant Patient Service Disruptions, Call for Thoughtful Reforms as Opposed to Repeated Cuts
10. Public Health Woefully Underfunded in Administrations Proposed Budget
11. 2009 Bush budget a disaster for HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Breaking Medicine Technology:$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Roche Diagnostics Opens State-of-the-Art Training Center in California 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2WaferGen Closes on Private Financings of Approx 246 2 Million 13975 1WaferGen Closes on Private Financings of Approx 246 2 Million 13975 2WaferGen Closes on Private Financings of Approx 246 2 Million 13975 3ABRISA Appoints Jim Veler as President CEO 13971 1ABRISA Appoints Jim Veler as President CEO 13971 2ABRISA Appoints Jim Veler as President CEO 13971 3